Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microfabrica is a leader in high-precision micro-scale additive manufacturing, specializing in the production of complex, multi-part metal mechanisms at the sub-millimeter scale. The company utilizes its proprietary MICA technology, which combines semiconductor lithography with advanced electrodeposition to create high-volume, high-precision components. In the healthcare sector, Microfabrica's capabilities enable the development of next-generation minimally invasive surgical instruments, interventional cardiology tools, and neurovascular devices. By providing design-to-manufacturing services, the company helps medical device OEMs overcome the limitations of traditional machining. Microfabrica was acquired by Technicolor (now Vantiva) in 2018 and continues to operate as a specialized manufacturing subsidiary.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microfabrica.